Hexagon Bio is a Menlo Park, California biotechnology company developing novel payloads for antibody-drug conjugates (ADCs) in oncology. The company designs next-generation ADC payloads intended to overcome resistance to current payloads and to expand the range of cancer indications ADCs can treat. - View it on GitHub